Inhaled ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections

por Sabuj, Mohammad Zaidur Rahman, Dargaville, Tim R., Nissen, Lisa, Islam, Nazrul
Publicado 2021

Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions

por Sabuj, Mohammad Zaidur Rahman, Rashid, Md Abdur, Dargaville, Tim R., Islam, Nazrul
Publicado 2022

Cytotoxic and Bactericidal Effects of Inhalable Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticles with Traces of Zinc Oxide

por Sabuj, Mohammad Zaidur Rahman, Huygens, Flavia, Spann, Kirsten M., Tarique, Abdullah A., Dargaville, Tim R., Will, Geoffrey, Wahab, Md Abdul, Islam, Nazrul
Publicado 2023

Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection

por Rashid, Md Abdur, Muneer, Saiqa, Mendhi, Jayanti, Sabuj, Mohammad Zaidur Rahman, Alhamhoom, Yahya, Xiao, Yin, Wang, Tony, Izake, Emad L., Islam, Nazrul
Publicado 2021